Nature Communications (Sep 2022)
Modeling human HSV infection via a vascularized immune-competent skin-on-chip platform
Abstract
Understanding host responses to Herpes simplex virus (HSV) in humans is challenging. Here the authors report a vascularised 3D ‘skin-on-chip’ that mimics human skin architecture and is competent to immune-cell and drug perfusion; they use this to model HSV infection.